Results 161 to 170 of about 78,708 (218)

Malaria vaccines since 2000: progress, priorities, products. [PDF]

NPJ Vaccines, 2020
Duffy PE, Patrick Gorres J.
europepmc   +1 more source

Vaccination against Malaria

Immunobiology, 1992
openaire   +2 more sources

Acceptance and affordability of malaria vaccines: issues relating to hesitancy and willingness to pay amongst Nigerian parents of under-five children. [PDF]

Malar J
Adigwe OP, Onavbavba G.
europepmc   +1 more source

Design and Evaluation of Chimeric Plasmodium falciparum Circumsporozoite Protein-Based Malaria Vaccines. [PDF]

Vaccines (Basel)
Stump WH, Klingenberg HJ, Ott AC, Gonzales DM, Burns JM.   +4 more
europepmc   +1 more source

Design and assessment of TRAP-CSP fusion antigens as effective malaria vaccines. [PDF]

PLoS One, 2020
Lu C, Song G, Beale K, Yan J, Garst E, Feng J, Lund E, Catteruccia F, Springer TA.   +8 more
europepmc   +1 more source

Generation of a Transgenic <i>Plasmodium cynomolgi</i> Parasite Expressing <i>Plasmodium vivax</i> Circumsporozoite Protein for Testing <i>P. vivax</i> CSP-Based Malaria Vaccines in Non-Human Primates. [PDF]

Vaccines (Basel)
Aleshnick M, Hegde S, Jennison C, Mikolajczak SA, Vaughan AM, Haumpy D, Martinson T, Straimer J, Wilder BK.   +8 more
europepmc   +1 more source

[Development of malaria vaccines-state of the art]. [PDF]

Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz, 2020
Metzger WG, Sulyok Z, Theurer A, Köhler C.   +3 more
europepmc   +1 more source

Willingness to accept malaria vaccines amongst women presenting at outpatient and immunization clinics in Enugu state, Southeast Nigeria. [PDF]

Malar J
Chinawa AT, Ossai EN, Onukwuli VO, Nduagubam OC, Uwaezuoke NA, Okafor CN, Chinawa JM.   +6 more
europepmc   +1 more source

A randomized first-in-human phase I trial of differentially adjuvanted Pfs48/45 malaria vaccines in Burkinabé adults. [PDF]

J Clin Invest
Tiono AB, Plieskatt JL, Ouedraogo A, Soulama BI, Miura K, Bougouma EC, Naghizadeh M, Barry A, Yaro JBB, Ezinmegnon S, Henry N, Ofori EA, Adu B, Singh SK, Konkobo A, Lövgren Bengtsson K, Diarra A, Carnrot C, Reimer JM, Ouedraogo A, Tienta M, Long CA, Ouedraogo IN, Sagara I, Sirima SB, Theisen M.   +25 more
europepmc   +1 more source

Leveraging malaria vaccines and mRNA technology to tackle the global inequity in pharmaceutical research and production towards disease elimination. [PDF]

Malar J
Amimo F.
europepmc   +1 more source